Susquehanna analyst Christopher Rolland raised the firm’s price target on Marvell (MRVL) to $100 from $80 and keeps a Positive rating on the shares. The firm previewed its earnings report where they expect better results/guidance driven by upside from both Inphi and Custom ASICs. Furthermore, management’s intra-quarter commentary suggests additional DC upside in 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRVL:
- Marvell price target raised to $110 from $105 at UBS
- Marvell’s Promising Growth: Buy Rating Backed by Strategic Partnerships and Optics Expansion
- Marvell initiated with a Hold at HSBC
- Hold Rating for Marvell: Balancing AI Optical Growth Against ASIC Strategy Concerns
- Trump Weekly: U.S. ends reciprocal food tariffs, levy on Brazil’s coffee